TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. has announced the conversion of five bonds into 277,777 new shares at a price of Euro 0.18 per share, as part of a convertible bond loan with GGHL. This conversion increases the company’s share capital by Euro 50,000, bringing the total number of shares to 14,949,535, and reflects ongoing strategic financial maneuvers to enhance its market position.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a global leader in numerical control technology and integrated milling systems, primarily serving the automotive and aerospace sectors. With over 50 years of experience, the company offers comprehensive solutions for the entire milling process and is listed on the Euronext Milan market of Borsa Italiana.
Average Trading Volume: 472,785
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2M
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.